FMN riboswitch
| FMN riboswitch (RFN element) | |
|---|---|
 Predicted secondary structure and sequence conservation of FMN | |
| Identifiers | |
| Symbol | FMN |
| Alt. Symbols | RFN |
| Rfam | RF00050 |
| Other data | |
| RNA type | Cis-reg; riboswitch |
| Domain(s) | Bacteria |
| GO | GO:0010181 |
| SO | SO:0000035 |
| PDB structures | PDBe |
The FMN riboswitch (also known as RFN element) is a highly conserved RNA element which is naturally occurring, and is found frequently in the 5'-untranslated regions of prokaryotic mRNAs that encode for flavin mononucleotide (FMN) biosynthesis and transport proteins.[1][2] This element is a metabolite-dependent riboswitch that directly binds FMN in the absence of proteins, thus giving it the ability to regulate RNA expression by responding to changes in the concentration of FMN.[3] In Bacillus subtilis, previous studies have shown that this bacterium utilizes at least two FMN riboswitches, where one controls translation initiation, and the other controls premature transcription termination.[4] Regarding the second riboswitch in Bacilius subtilis, premature transcription termination occurs within the 5' untranslated region of the ribDEAHT operon, precluding access to the ribosome-binding site of ypaA mRNA.[3][5] FMN riboswitches also have various magnesium and potassium ions dispersed throughout the nucleotide structure, some of which participate in binding of FMN.[6]
In the bacterium Fusobacterium nucleatum, FMN binding has been studied. The FMN riboswitch is able to selectively bind the FMN molecule due to several distinct nucleic acid residues, as well as some of the magnesium ions present in the overall riboswitch structure. FMN's planar isoalloxazine ring system intercalates between A48 and A85 residues on the riboswitch, thereby providing a continuous stacking alignment. Further, the uracil-like edge of the ring system forms specific Watson–Crick-like hydrogen bonds with a highly conserved A99 residue on the riboswitch.[6] An additional structural moiety of FMN, the ribityl group, uses one of its four oxygens for hydrogen bonding, whereas phosphate oxygens form additional hydrogen bonds with Watson–Crick edges of several conserved guanines.[7] The interaction between the phosphate of FMN and the RNA is also bridged by a magnesium ion, which directly coordinates the phosphate oxygen of FMN and a G33 residue, and forms several water-mediated contacts with neighboring nucleotides.[6]
Function of FMN Riboswitch[edit]
The function of the FMN riboswitch is twofold; first, riboswitches contain an aptamer component, which allows this RNA molecule to bind to its target molecule, FMN, resulting in a series of conformational changes. These conformational changes occur between the bound and unbound states, and are contingent upon the presence or absence of FMN. Previous research has proposed that this riboswitch operates by forming an intrinsic terminator stem when FMN is present in sufficient amounts but folds into an alternative structure when FMN is absent.[4] Additional studies conducted on this riboswitch also suggest that these conformational changes in the structure of the FMN riboswitch are localized to specific nucleotide regions that form the binding pocket of this molecule.[8] These findings are congruent with binding events seen in other riboswitches and RNA molecules.[8] The second function of the FMN riboswitch is an expression platform, which either inhibits or activates expression of the genes associated with FMN.
FMN Riboswitch's Role in Disease[edit]
While riboswitches are not present in mammalian eukaryotic cells, they are present in prokaryotic cells, thus making them possible targets for antibiotic drug development. Special interest is had with FMN riboswitches present in Fusobacterium nucleatum, as this bacterium plays a role in periodontal disease and other human infections, and is considered one of the most pathogenic bacteria of the genus.[6] The inherent plasticity of the FMN-binding pocket and the availability of large openings make the FMN riboswitch an attractive target for the structure-based design of analog FMN antimicrobial compounds.[6]
References[edit]
- ^ Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS (2002). "Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation". Nucleic Acids Res. 30 (14): 3141–3151. doi:10.1093/nar/gkf433. PMC 135753. PMID 12136096.
- ^ Gelfand MS, Mironov AA, Jomantas J, Kozlov YI, Perumov DA (1999). "A conserved RNA structure element involved in the regulation of bacterial riboflavin synthesis genes". Trends Genet. 15 (11): 439–442. doi:10.1016/S0168-9525(99)01856-9. PMID 10529804.
- ^ a b Mironov, AS; Gusarov I; Rafikov R; Lopez LE; Shatalin K; Kreneva RA; Perumov DA; Nudler E (2002). "Sensing small molecules by nascent RNA: a mechanism to control transcription in bacteria". Cell. 111 (5): 747–756. doi:10.1016/S0092-8674(02)01134-0. PMID 12464185. S2CID 16183979.
- ^ a b Wickiser, J. Kenneth; Winkler, Wade C.; Breaker, Ronald R.; Crothers, Donald M. (2005-04-01). "The Speed of RNA Transcription and Metabolite Binding Kinetics Operate an FMN Riboswitch". Molecular Cell. 18 (1): 49–60. doi:10.1016/j.molcel.2005.02.032. ISSN 1097-2765. PMID 15808508.
- ^ Winkler, WC; Cohen-Chalamish S; Breaker RR (2002). "An mRNA structure that controls gene expression by binding FMN". Proc Natl Acad Sci USA. 99 (25): 15908–15913. Bibcode:2002PNAS...9915908W. doi:10.1073/pnas.212628899. PMC 138538. PMID 12456892.
- ^ a b c d e Serganov, Alexander (25 January 2009). "NIH Library of Medicine". Nature. 458 (7235): 233–237. Bibcode:2009Natur.458..233S. doi:10.1038/nature07642. PMC 3726715. PMID 19169240.
- ^ a b Serganov A, Huang L, Patel DJ (2009). "Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch". Nature. 458 (7235): 233–237. Bibcode:2009Natur.458..233S. doi:10.1038/nature07642. PMC 3726715. PMID 19169240.
- ^ a b Pedrolli, Danielle (22 October 2015). "National Library of Medicine". Proceedings of the National Academy of Sciences of the United States of America. 112 (45): 14054–14059. doi:10.1073/pnas.1515024112. PMC 4653141. PMID 26494285.